2021-11 | Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability and action | Elkamhawy, Ahmed; Kim, Hyeon Jeong; Elsherbeny, Mohamed H.; Paik, Sora; Park, Jong-Hyun; Gotina, Lizaveta; Abdellattif, Magda H.; Gouda, Noha A.; Cho, Jungsook; Lee, Kyeong; Pae, Ae Nim; Park, Ki Duk; Roh, Eun Joo |
2021-10 | Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies | Elkamhawy, A.; Paik, S.; Park, J.-H.; Kim, H.J.; Hassan, A.H.E.; Lee, K.; Park, K.D.; Roh, E.J. |
2021-07 | Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis | Cho, Hyun-U; Kim, Sunpil; Sim, Jeongeun; Yang, Seulkee; An, Heeyoung; Nam, Min-Ho; Jang, Dong-Pyo; Lee, C. Justin |
2021-10 | Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress | Elkamhawy, Ahmed; Woo, Jiyu; Gouda, Noha A.; Kim, Jushin; Nada, Hossam; Roh, Eun Joo; Park, Ki Duk; Cho, Jungsook; Lee, Kyeong |